However, GSK-3β could also display a tumor-enhancing role, as it has been reported that it promotes NF-κB binding to target genes (e.g., XIAP, BCL2), given that in CLL cells GSK-3β accumulates in the nucleus [128]. This evidence concerns the gene GSK3B and neoplasm.